Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOXFRENCH26 – PRODIGE93 - PANACHE02 Trial

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 5aa25ea9fc9365b8bdba3bee178abb753299bd08
First added on: Jan 17, 2026